BRPI0718307A2 - Uso de oligossacarídeos indigeríveis, composição nutricional, oligossacarídeos indigeríveis, e, método para melhora de resistência à insulina, prevenção da queda glicêmica pós-prandial e/ou diminuição da resposta à glicose pós-prandial de uma refeição - Google Patents

Uso de oligossacarídeos indigeríveis, composição nutricional, oligossacarídeos indigeríveis, e, método para melhora de resistência à insulina, prevenção da queda glicêmica pós-prandial e/ou diminuição da resposta à glicose pós-prandial de uma refeição

Info

Publication number
BRPI0718307A2
BRPI0718307A2 BRPI0718307-0A2A BRPI0718307A BRPI0718307A2 BR PI0718307 A2 BRPI0718307 A2 BR PI0718307A2 BR PI0718307 A BRPI0718307 A BR PI0718307A BR PI0718307 A2 BRPI0718307 A2 BR PI0718307A2
Authority
BR
Brazil
Prior art keywords
response
indigestible oligosaccharides
glandose
prevention
post
Prior art date
Application number
BRPI0718307-0A2A
Other languages
English (en)
Inventor
Houkje Bouritius
Laere Katrien Maria Jozefa Van
Robert Johan Joseph Hageman
De Heijning Hubertus Josephus Van
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI0718307A2 publication Critical patent/BRPI0718307A2/pt
Publication of BRPI0718307B1 publication Critical patent/BRPI0718307B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BRPI0718307-0A 2006-11-02 2007-11-02 uso de oligossacarídeos indigeríveis e composições nutricionais BRPI0718307B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2006/050275 WO2008054193A1 (en) 2006-11-02 2006-11-02 Nutritional products that comprise saccharide oligomers
NLPCT/NL2006/050275 2006-11-02
PCT/NL2007/050530 WO2008054211A1 (en) 2006-11-02 2007-11-02 Nutritional products comprising saccharide oligomers

Publications (2)

Publication Number Publication Date
BRPI0718307A2 true BRPI0718307A2 (pt) 2014-04-29
BRPI0718307B1 BRPI0718307B1 (pt) 2020-11-17

Family

ID=38134585

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0718307-0A BRPI0718307B1 (pt) 2006-11-02 2007-11-02 uso de oligossacarídeos indigeríveis e composições nutricionais

Country Status (17)

Country Link
US (1) US8637487B2 (pt)
EP (1) EP2086353B1 (pt)
JP (1) JP2010515665A (pt)
CN (1) CN101626696B (pt)
AU (1) AU2007314732A1 (pt)
BR (1) BRPI0718307B1 (pt)
CA (1) CA2668312C (pt)
DK (1) DK2086353T3 (pt)
ES (1) ES2714575T3 (pt)
HU (1) HUE042644T2 (pt)
IL (1) IL198517A0 (pt)
MX (1) MX2009004814A (pt)
PL (1) PL2086353T3 (pt)
RU (1) RU2469557C2 (pt)
TR (1) TR201903494T4 (pt)
WO (2) WO2008054193A1 (pt)
ZA (1) ZA200903497B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
JP5475673B2 (ja) * 2009-01-19 2014-04-16 ニュートリー株式会社 低濃度の栄養組成物
EP2400839B1 (en) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2010104374A1 (en) * 2009-03-09 2010-09-16 N.V. Nutricia Nutritional composition inducing a postprandial endocrine response
EP2427499A1 (en) * 2009-05-07 2012-03-14 Tate&Lyle Ingredients France SAS Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
IT1399244B1 (it) * 2009-07-31 2013-04-11 Pharmarte S R L Formulazione di barretta specifica per la gravidanza.
US8617636B2 (en) * 2009-10-01 2013-12-31 Roquette Freres Carbohydrate compositions having a greater impact on the insulinemic response than on the glycemic response, their preparation and their uses
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
DE102011012494A1 (de) * 2011-02-25 2012-08-30 Humana Milchunion Eg Prebiotische Kohlenhydrat-Zusammensetzungen
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
US9636367B2 (en) * 2011-10-18 2017-05-02 Nestec S.A. Composition for use in increasing insulin sensitivity and/or reducing insulin resistance
JP5927663B2 (ja) * 2011-10-21 2016-06-01 松谷化学工業株式会社 血糖値の上昇が緩やかな糖質組成物及び飲食品
HK1246600B (en) 2015-01-26 2020-04-09 Cadena Bio, Inc. Oligosaccharide compositions for use animal feed and methods of producing thereof
HK1246604A1 (zh) * 2015-01-26 2018-09-14 Cadena Bio, Inc. 用作食品成分的寡糖组合物和其制造方法
US10190142B2 (en) * 2016-01-25 2019-01-29 King-Prebiotics Biotechnology (Tw) Co., Ltd. High-purity galactooligosaccharide compositions, preparations, and applications thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2097041C1 (ru) * 1994-11-22 1997-11-27 Чепурной Иван Петрович Способ лечения сахарного диабета
DE69818594T2 (de) * 1997-06-23 2004-09-23 Société des Produits Nestlé S.A. Verwendung einer nutritiven Zusammensetzung zur Herstellung einer flüssigen Zusammensetzung für Diabetiker
DE69918680T2 (de) * 1999-05-20 2005-07-28 Société des Produits Nestlé S.A. Verfahren zur Erhöhung der Propionateproduktion im Gastrointestinaltrakt
DE19961182B4 (de) * 1999-12-18 2006-01-12 Südzucker AG Mannheim/Ochsenfurt Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung
US6774111B1 (en) * 2000-03-14 2004-08-10 Abbott Laboratories Carbohydrate system and a method for providing nutrition to a diabetic
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
JP2002306131A (ja) 2001-04-16 2002-10-22 Takara Bio Inc 食品、飲料又は飼料
CN1164186C (zh) * 2001-04-29 2004-09-01 上海光明乳业股份有限公司 益菌奶及其制造方法
MXPA03010937A (es) * 2001-05-31 2004-02-27 Abbott Lab Sistema de fibra de viscosidad controlada por acido y usos del mismo.
US6989166B2 (en) * 2001-12-20 2006-01-24 N.V. Nutricia Soft drink replacer
JP4401659B2 (ja) 2002-02-04 2010-01-20 協和発酵バイオ株式会社 インスリン分泌促進剤
DE60301677T2 (de) * 2002-02-04 2006-07-06 Kyowa Hakko Kogyo Co., Ltd. Pharmazeutische und Lebenmittelzusammensetzungen mit einem Di- oder Oligosaccharid, das die Insulinfreisetzung steigert
JP4328490B2 (ja) * 2002-03-01 2009-09-09 天野エンザイム株式会社 飲食品の風味改善剤及びこれが添加された食品並びに飲食品の風味改善方法
JP4556009B2 (ja) * 2002-05-31 2010-10-06 塩水港精糖株式会社 抗炎症剤、アレルギー性疾患予防又は改善剤及び機能性食品
FR2844453B1 (fr) * 2002-09-13 2006-05-19 Agronomique Inst Nat Rech Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii
JP2004149471A (ja) 2002-10-31 2004-05-27 Shiratori Pharmaceutical Co Ltd 血糖低下剤
PL1675481T3 (pl) * 2003-10-24 2009-03-31 Nutricia Nv Kompozycja synbiotyczna dla niemowląt
CN1545937A (zh) * 2003-12-03 2004-11-17 上海交大昂立股份有限公司 一种含有益生元的儿童保健食品及其制备方法
US8501676B2 (en) 2004-07-19 2013-08-06 N.V. Nutricia Preparation for use of aspartate for regulating glucose levels in blood
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
CN1332619C (zh) * 2004-09-20 2007-08-22 段治义 魔芋低聚糖快速减肥食品及其制作方法
EP1656839A1 (en) * 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
ES2419205T3 (es) * 2005-04-06 2013-08-19 Nestec S.A. Composición para mejorar la regulación de la glicemia y la acción de la insulina, por vía nutritiva

Also Published As

Publication number Publication date
CN101626696A (zh) 2010-01-13
WO2008054211A9 (en) 2008-10-16
WO2008054211A1 (en) 2008-05-08
AU2007314732A1 (en) 2008-05-08
RU2469557C2 (ru) 2012-12-20
BRPI0718307B1 (pt) 2020-11-17
CA2668312C (en) 2015-08-25
TR201903494T4 (tr) 2019-04-22
PL2086353T3 (pl) 2019-05-31
CN101626696B (zh) 2016-01-20
US8637487B2 (en) 2014-01-28
JP2010515665A (ja) 2010-05-13
WO2008054193A1 (en) 2008-05-08
CA2668312A1 (en) 2008-05-08
RU2009120697A (ru) 2010-12-10
DK2086353T3 (en) 2019-03-25
IL198517A0 (en) 2010-02-17
US20100069327A1 (en) 2010-03-18
EP2086353A1 (en) 2009-08-12
ES2714575T3 (es) 2019-05-29
ZA200903497B (en) 2010-05-26
MX2009004814A (es) 2009-07-17
EP2086353B1 (en) 2018-12-12
HUE042644T2 (hu) 2019-07-29

Similar Documents

Publication Publication Date Title
BRPI0718307A2 (pt) Uso de oligossacarídeos indigeríveis, composição nutricional, oligossacarídeos indigeríveis, e, método para melhora de resistência à insulina, prevenção da queda glicêmica pós-prandial e/ou diminuição da resposta à glicose pós-prandial de uma refeição
HUE038279T2 (hu) Klotho-béta-agonista antitest cukorbetegség vagy inzulinrezisztencia kezelésében történõ alkalmazásra
BRPI0911681A2 (pt) composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula
BRPI0816097A2 (pt) composição farmacêutica, método para tratar eritema em um paciente com rosácea, e, uso de uma composição.
IL192631A (en) A drug containing an isolated antibody or a functional portion thereof, pharmaceutical preparations and a kit containing it
BRPI0820967A2 (pt) Uso de uma composição, composição farmacêutica e método para tratamento, melhora ou profilaxia dos sintomas de uma doença inflamatória
BRPI0816133A2 (pt) Composição que emite flavorizante, dispositivo que emite flavorizante, tablete comprimido ou moldado, produto alimentício acondicionado, e, métodos para fabricar um dispositivo que emite flavorizante e uma composição que emite flavorizante.
EP1980203B8 (en) Blood sensor and blood test apparatus having the same
DK2835059T3 (da) Flydende, enteral ernæringssammensætning med højt proteinindhold
IL197831A (en) Human antibodies that bind 4cxcr, preparations containing them and their uses
PT2049097T (pt) Composição e método para ligar acetaldeído no estômago
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
BRPI0916576A2 (pt) pelo menos uma entidade química, composição farmacêutica, e, método para tratar uma condição ou distúrbio.
WO2009051706A3 (en) Peptide compounds for treating obesity and insulin resistance
WO2007112069A3 (en) Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
IL196965A (en) Analogues of (r, r) or (s, r) phenoterol, their pharmaceutical composition containing them and their use for the treatment of heart failure
DK2227539T3 (da) Sammensætning til menneske- og/eller dyreernæring, anvendelser deraf og gær
BRPI0719250A2 (pt) Métodos e composições com opalescência reduzida.
EP2103653A4 (en) COMPOSITION AND COMPOSITION COMPREHENSIVE LIGHT-EMITTING ITEM
BRPI0719272A2 (pt) Composição de enzima, e, método para preparar uma composição de enzima.
EP1927603A4 (en) COMPOSITION OF SYRUP, RESIN MORTAR COMPOSITION AND METHOD OF APPLICATION
WO2008022169A8 (en) Controlled flow polymer blends and products including the same
PL2128253T3 (pl) Przeciwciało anty-FGF23 i kompozycja zawierająca takie przeciwciało
BRPI0819930A2 (pt) composto, éster de pró-droga, composição farmacêutica, e, métodos para tratar uma doença ou condição mediada por sglt e para tratar diabetes
EP2119367A4 (en) OIL AND FAT COMPOSITION AND FOOD OR DRINK CONTAINING THE OIL AND FAT COMPOSITION

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A23L 1/29; A61P 3/10.

Ipc: A23L 33/21 (2016.01), A23L 33/10 (2016.01), A23L 3

Ipc: A23L 33/21 (2016.01), A23L 33/10 (2016.01), A23L 3

B15K Others concerning applications: alteration of classification

Ipc: A23L 33/21 (2016.01), A23L 33/10 (2016.01), A23L 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS.